Sharps Technology Income from Continuous Operations 2022-2024 | STSS

Sharps Technology income from continuous operations from 2022 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change

Sharps Technology Income from Continuous Operations 2022-2024 | STSS

Sharps Technology income from continuous operations from 2022 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$199.5B
Stryker (SYK)$146.1B
Boston Scientific (BSX)$129.1B
Medtronic (MDT)$110.3B
EssilorLuxottica (ESLOY)$110B
Lonza Group Ag (LZAGY)$45B
Haleon (HLN)$42.1B
GE HealthCare Technologies (GEHC)$37.9B
ResMed (RMD)$34B
Terumo (TRUMY)$29.4B
Koninklijke Philips (PHG)$24.2B
Zimmer Biomet Holdings (ZBH)$21.7B
Insulet (PODD)$18.3B
Baxter (BAX)$16.2B
Smith & Nephew SNATS (SNN)$10.8B
Bio-Rad Laboratories (BIO)$9.8B
BellRing Brands (BRBR)$9.4B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$5.6B
TG Therapeutics (TGTX)$4.8B
Haemonetics (HAE)$4.6B
ICU Medical (ICUI)$4.2B
Prestige Consumer Healthcare (PBH)$4.1B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.5B
Neogen (NEOG)$3.2B
Agios Pharmaceuticals (AGIO)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.6B